AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2025)
AtaiBeckley (ATAI) posted Long-Term Debt Issuances of -$5.0 million for Q4 2024, down 148.24% sequentially from $10.4 million in Q4 2022.
Analysis
AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends
AtaiBeckley has reported Long-Term Debt Issuances for 4 years, with the latest figure at -$5.0 million in Q4 2024.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$5.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.4 million (down 61.47% YoY) and the FY2022 annual result came in at $15.0 million, up 520.6% from the prior year.
- Long-Term Debt Issuances retreated to -$5.0 million in Q4 2024 per ATAI's latest filing, from $10.4 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $18.1 million in Q3 2020 and troughed at -$5.0 million in Q4 2024.
- A 4-year average of $4.9 million and a median of $3.0 million in 2021 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2021 and 2022: Long-Term Debt Issuances sank 105.95% in 2021, then soared 328.84% in 2022.
- Over 4 years, Long-Term Debt Issuances stood at $5.8 million in 2020, then slumped by 58.33% to $2.4 million in 2021, then jumped by 328.84% to $10.4 million in 2022, then plunged by 148.24% to -$5.0 million in 2024.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$5.0 million, $10.4 million, and $3.6 million for Q4 2024, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 40.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 18.39 Mn |
| Jun 30, 2025 | 18.39 Mn |
| Mar 31, 2025 | 59.77 Mn |
| Mar 31, 2025 | 59.77 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2022 | 13.92 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Dec 31, 2021 | 787,000.00 |
| Sep 30, 2021 | 4.48 Mn |
| Jun 30, 2021 | 832,000.00 |
| Mar 31, 2021 | 756,000.00 |
| Dec 31, 2020 | 7.00 Mn |
| Sep 30, 2020 | 18.06 Mn |
| Jun 30, 2020 | 9.71 Mn |